Enhancing Telehealth Strategies to Support Retention and Adherence to Antiretroviral Therapy (ART)
The purpose of this Notice of Funding Opportunity (NOFO) is to support the evaluation of the effectiveness of an enhanced telehealth program to improve adherence to HIV prevention and treatment medication, while also exploring the “implementability” of its practice into routine care.
Specifically, the awardee will, via a hybrid effectiveness-implementation research design:
1) evaluate the effectiveness of an enhanced telehealth program for maintenance of HIV medication adherence among clinically stable people with HIV (PWH) and pre-exposure prophylaxis (PrEP) medication adherence for those at risk of HIV infection; and 2) identify potential implementation facilitators and challenges by evaluating the delivery of these strategies.
Furthermore, the recipient will evaluate the cost and cost-effectiveness of providing telehealth to patients on antiretroviral therapy (ART) or PrEP, and evaluate program enhancements that will include, but may be not limited to, multi-month prescription refills, biospecimen sample self-collection, and the use of specialized staff such as community health workers and patient navigators.
This enhanced telehealth program will focus on those disproportionately affected by HIV or at risk for HIV infection, including cis-gender Black or African American (hereafter referred to as Black) women with HIV, transgender women.
and gay, bisexual and other men who have sex with men (hereafter referred to as MSM).
Specifically, the awardee will, via a hybrid effectiveness-implementation research design:
1) evaluate the effectiveness of an enhanced telehealth program for maintenance of HIV medication adherence among clinically stable people with HIV (PWH) and pre-exposure prophylaxis (PrEP) medication adherence for those at risk of HIV infection; and 2) identify potential implementation facilitators and challenges by evaluating the delivery of these strategies.
Furthermore, the recipient will evaluate the cost and cost-effectiveness of providing telehealth to patients on antiretroviral therapy (ART) or PrEP, and evaluate program enhancements that will include, but may be not limited to, multi-month prescription refills, biospecimen sample self-collection, and the use of specialized staff such as community health workers and patient navigators.
This enhanced telehealth program will focus on those disproportionately affected by HIV or at risk for HIV infection, including cis-gender Black or African American (hereafter referred to as Black) women with HIV, transgender women.
and gay, bisexual and other men who have sex with men (hereafter referred to as MSM).
Related Programs
Prevention of Disease, Disability, and Death by Infectious Diseases
Department of Health and Human Services
Agency: Department of Health and Human Services
Office: Centers for Disease Control and Prevention - ERA
Estimated Funding: $3,600,000
Office: Centers for Disease Control and Prevention - ERA
Estimated Funding: $3,600,000
Who's Eligible
Obtain Full Opportunity Text:
USAID/Haiti web site
Additional Information of Eligibility:
N/A
Full Opportunity Web Address:
http://www.usaid.gov/ht/
Contact:
Agency Email Description:
fzp0@cdc.gov
Agency Email:
Date Posted:
2023-01-10
Application Due Date:
Archive Date:
2023-04-16
Social Entrepreneurship
Spotlight
Rwanda as Social Entrepreneur Fund Beneficiary
The Republic of Rwanda has been picked as one of the six African countries as beneficiaries for a new fellowship fund program designed at supporting social entrepreneurs in tackling issues on food security.
Learn How to Identify and Avoid Grant Scams
